-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Day One Biopharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2021 to Q1 2024.
- Day One Biopharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $23K, a 283% increase year-over-year.
- Day One Biopharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $36K, a 42.9% decline from 2022.
- Day One Biopharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $63K, a 215% increase from 2021.
- Day One Biopharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $20K, a 25% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)